Literature DB >> 31902927

Multiple Biological Aspects of Eosinophils in Host Defense, Eosinophil-Associated Diseases, Immunoregulation, and Homeostasis: Is Their Role Beneficial, Detrimental, Regulator, or Bystander?

Akira Kanda1,2, Yun Yasutaka1, Dan Van Bui1, Kensuke Suzuki1, Shunsuke Sawada1, Yoshiki Kobayashi1,2, Mikiya Asako1,2, Hiroshi Iwai1.   

Abstract

Eosinophils are innate immune leukocytes and play important roles as terminal effector cells owing to their mediators, such as tissue-destructive cationic proteins, cytokines, chemokines, and lipid mediators. Historically, they are not only considered an important player in host defense against parasitic, viral, fungal, and bacterial infections but also implicated in the pathogenesis of eosinophil-associated diseases, such as allergic rhinitis, asthma, eosinophilic chronic rhinosinusitis, esophagitis, atopic dermatitis, myopathies, and hypereosinophilic syndrome. Moreover, recent studies have shown that eosinophils have an immune regulatory and homeostatic function. Interestingly, there is emerging evidence that eosinophils are accumulated through adoptive T-helper 2 (Th2) and innate Th2 responses, mechanisms of the classical allergen-specific immunoglobulin E (IgE)-mediated response, and group 2 innate lymphoid cell-derived interleukin-5, respectively. Furthermore, in agreement with current concepts of eosinophil subtypes, it has been shown that resident and phenotypically distinct eosinophils, i.e., resident and recruited inflammatory eosinophils, exist in inflamed sites, and each has different functions. Thus, the classical and novel studies suggest that eosinophils have multiple functions, and their roles may be altered by the environment. In this article, we review multiple biological aspects of eosinophils (novel and classical roles), including their beneficial and detrimental effects, immunoregulation, and homeostatic function.

Entities:  

Keywords:  allergic rhinitis (AR); asthma; eosinophil; eosinophilic chronic rhinosinusitis (ECRS)

Mesh:

Year:  2020        PMID: 31902927     DOI: 10.1248/bpb.b19-00892

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

Review 1.  Neuro-Immune Regulation in Inflammation and Airway Remodeling of Allergic Asthma.

Authors:  Ning Zhang; Jing Xu; Congshan Jiang; Shemin Lu
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

2.  Clinical investigation of a unique type of hypothalamic adrenal insufficiency.

Authors:  Kaori Takeshita; Ichiro Abe; Mai Nagata; Kentaro Ochi; Yuki Senda; Midori Koga; Kenji Ohe; Makiko Abe; Tadachika Kudo; Kunihisa Kobayashi
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

Review 3.  Eosinophils in the Field of Nasal Polyposis: Towards a Better Understanding of Biologic Therapies.

Authors:  Thibault Vanderhaegen; Isabelle Gengler; Arnaud Dendooven; Cecile Chenivesse; Guillaume Lefèvre; Geoffrey Mortuaire
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-26       Impact factor: 8.667

4.  Identification of key genes and pathways between mild-moderate and severe asthmatics via bioinformatics analysis.

Authors:  Xiaolu Wu; Ran Li; Qu Xu; Feng Liu; Yue Jiang; Min Zhang; Meiling Tong
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.996

5.  Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease.

Authors:  Ling-Sai Chang; Kuang-Den Chen; Ying-Hsien Huang; Ho-Chang Kuo
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

Review 6.  Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.

Authors:  Peter Valent; Lina Degenfeld-Schonburg; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Hans-Uwe Simon; Andreas Reiter; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-05-30       Impact factor: 9.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.